Dystrophie musculaire de Duchenne Dystrophie musculaire de Duchenne Dystrophie musculaire de Duchenne

Archives

Monthly Archive for: "June, 2017"
Portrait of Duchenne – Ataluren a promising treatment for DMD
By La Force DMD
In Treatments
Posted 2 June 2017

Portrait of Duchenne – Ataluren a promising treatment for DMD

Ellen Welch, PhD Group leader biology at PTC Therapeutics, South Plainfield, New Jersey, USA   In this fourth interview of our series “Portrait of Duchenne”, La Force DMD talks with Ellen [...]

Articles récents

  • The global day of giving
  • EMBARK, gene therapy for the treatment of DMD
  • Part B of MOMENTUM study of SRP-5051 in patients with DMD
  • World Duchenne Awareness Day 2021
  • ENDEAVOR, gene therapy for DMD

Catégories

  • Fundraising
  • in the Medias
  • News
  • Research
  • Testimonial
  • Treatments

+

Restez informé

    LA Force - Dystrophie musculaire de Duchenne

    La Force dmd - Tous droits réservés - Organisme à but non lucratif - NEQ 1170049614
    La Force dmd La Force dmd
    • S’informer
      • Frequently Asked Questions
    • Support our work
    • Agir
      • Quick guige – Management of DMD
      • Take action – What’s your genetic profile?
      • Take action – Subscribe to registries
    • Aller plus loin
      • Go further – How can you access a new treatment?
      • Go further – How do researchers test new treatments?
      • Go further – How are drugs approved for use in Canada?
      • Go further – Who decides to reimburse drug costs?
    • Blog
    • About us
    • Contact-us
    • Français